138 related articles for article (PubMed ID: 6800290)
1. Pneumococcal vaccine: clinical efficacy and effectiveness.
Schwartz JS
Ann Intern Med; 1982 Feb; 96(2):208-20. PubMed ID: 6800290
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
Landesman SH; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S184-97. PubMed ID: 7025158
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal polysaccharide vaccine. Recommendation of the Immunization Practices Advisory Committee.
Ann Intern Med; 1982 Feb; 96(2):203-5. PubMed ID: 6277218
[TBL] [Abstract][Full Text] [Related]
4. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
Austrian R
J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials.
Cornu C; Yzèbe D; Léophonte P; Gaillat J; Boissel JP; Cucherat M
Vaccine; 2001 Sep; 19(32):4780-90. PubMed ID: 11535330
[TBL] [Abstract][Full Text] [Related]
6. Serum antibody responses of high-risk children and adults to vaccination with capsular polysaccharides of Streptococcus pneumoniae.
Giebink GS; Le CT; Cosio FG; Spika JS; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S168-78. PubMed ID: 7025156
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccine in the institutionalized elderly: review of past and recent studies.
Bentley DW
Rev Infect Dis; 1981; 3 Suppl():S61-70. PubMed ID: 6169131
[No Abstract] [Full Text] [Related]
8. Pneumococcal vaccine trials in Papua New Guinea: relationships between epidemiology of pneumococcal infection and efficacy of vaccine.
Riley ID; Lehmann D; Alpers MP
Rev Infect Dis; 1991; 13 Suppl 6():S535-41. PubMed ID: 1862283
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal vaccine recommendation. American College of Physicians; Philadelphia, Pennsylvania Endorsed by the advisory committee on immunization practices, council of medical societies.
Ann Intern Med; 1982 Feb; 96(2):206-7. PubMed ID: 7059068
[TBL] [Abstract][Full Text] [Related]
10. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal vaccine in the United States. A critical analysis.
Hirschmann JV; Lipsky BA
JAMA; 1981 Sep; 246(13):1428-32. PubMed ID: 7265447
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
13. Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine.
Ammann AJ; Schiffman G; Addiego JE; Wara WM; Wara DW
Rev Infect Dis; 1981; 3 Suppl():S160-7. PubMed ID: 7280446
[TBL] [Abstract][Full Text] [Related]
14. Response to pneumococcal vaccine among children with Hodgkin's disease.
Donaldson SS; Vosti KL; Berberich FR; Cox RS; Kaplan HS; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S133-43. PubMed ID: 6895119
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal vaccine in the institutionalized elderly: design of a nonrandomized trial and preliminary results.
Bentley DW; Ha K; Mamot K; Moon D; Moore L; Poletto P; Springett A
Rev Infect Dis; 1981; 3 Suppl():S71-81. PubMed ID: 7280449
[No Abstract] [Full Text] [Related]
16. Pneumococcal vaccine in sickle cell disease: IgG and IgM antibody response.
Barrett DJ; Ammann AJ
Rev Infect Dis; 1981; 3 Suppl():S179-82. PubMed ID: 6169129
[TBL] [Abstract][Full Text] [Related]
17. Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report.
Addiego JE; Ammann AJ; Schiffman G; Baehner R; Higgins G; Hammond D
Lancet; 1980 Aug; 2(8192):450-2. PubMed ID: 6106099
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.
Broome CV; Facklam RR; Fraser DW
N Engl J Med; 1980 Sep; 303(10):549-52. PubMed ID: 6995835
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
Caro-Aguilar I; Indrawati L; Kaufhold RM; Gaunt C; Zhang Y; Nawrocki DK; Giovarelli C; Winters MA; Smith WJ; Heinrichs J; Skinner JM
Vaccine; 2017 Feb; 35(6):865-872. PubMed ID: 28087148
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia.
Weintrub PS; Schiffman G; Addiego JE; Matthay KK; Vichinsky E; Johnson R; Lubin B; Mentzer WC; Ammann AJ
J Pediatr; 1984 Aug; 105(2):261-3. PubMed ID: 6747758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
